What is the appropriate outpatient management plan for an 85-year-old woman with symptomatic severe aortic stenosis presenting with fatigue?

Outpatient Management Plan for 85-Year-Old Woman with Symptomatic Severe Aortic Stenosis

This patient requires urgent referral to a Heart Team for transcatheter aortic valve implantation (TAVI), as TAVI is the preferred intervention for patients over 80 years old with symptomatic severe aortic stenosis, and conservative management carries a mortality rate of approximately 2% per month. 1, 2

Immediate Actions (Within 1-2 Weeks)

1. Heart Team Referral

• Refer immediately to a multidisciplinary Heart Team (interventional cardiologist, cardiac surgeon, imaging specialist) for TAVI evaluation 1
• At age 85, TAVI is strongly preferred over surgical aortic valve replacement (SAVR) based on current guidelines 1
• Time from treatment decision to TAVI averages 2.1 months versus 4.8 months for SAVR 2

2. Pre-Intervention Assessment Required

Before the Heart Team evaluation, obtain:

Functional Status:

• Frailty assessment using Fried's criteria (pre-frail, early frail, or frail) 3
• Activities of daily living (Katz index) - this directly impacts prognosis 2
• NYHA functional class documentation

Additional Cardiac Workup:

• Check for "red flags" suggesting concurrent cardiac amyloidosis (present in up to 15% of elderly AS patients): 4
  • Left ventricular hypertrophy disproportionate to valve severity
  • "Apical sparing" pattern on strain imaging
  • If present, obtain Tc99m-PYP bone scintigraphy
• Assess left ventricular ejection fraction (LVEF) - if <50%, dobutamine stress echo needed to distinguish true-severe from pseudo-severe AS 1
• Coronary angiography or CT angiography to assess for coronary disease

Surgical Risk Stratification:

• Calculate STS-PROM score (Society of Thoracic Surgeons Predicted Risk of Mortality)
• At age 85 with STS-PROM >8%, TAVI is indicated; even if ≤8%, TAVI equals or exceeds SAVR 1

Medical Management While Awaiting Intervention

Symptom Control (NOT Disease-Modifying)

Critical caveat: There is no effective medical therapy that alters AS progression or improves survival 5

• Diuretics cautiously for volume overload symptoms - avoid excessive preload reduction
• Avoid vasodilators (ACE inhibitors, ARBs, nitrates) - can cause hypotension in fixed cardiac output state
• Beta-blockers with extreme caution - may worsen symptoms by preventing compensatory tachycardia
• Maintain adequate blood pressure to ensure coronary perfusion

Activity Modification

• Avoid strenuous physical activity
• Monitor for symptom progression (worsening dyspnea, syncope, angina)

Post-TAVI Outpatient Management Plan

Follow-Up Schedule

• Heart Team manages first 30 days (highest risk period for procedural complications) 6
• Transfer to primary cardiologist at 30 days 6
• Cardiologist visits: 6 months post-procedure, then annually (more frequently if complications) 6
• Primary care/geriatrician: Involved throughout for comorbidity management 6

Long-Term Monitoring Components

1. Prosthetic Valve Surveillance:

• Serial echocardiography to assess valve function and durability
• Monitor for paravalvular leak, valve thrombosis

2. Cardiac Conduction Monitoring:

• High risk of heart block post-TAVI - monitor for bradycardia, syncope
• May require pacemaker implantation

3. Antithrombotic Therapy:

• Follow institutional protocols (typically dual antiplatelet therapy initially, then single agent)

4. Comorbidity Management:

• Readmission rates exceed 40% in first year - 60% are non-cardiac causes 6
• Common readmission diagnoses: respiratory problems, infections, bleeding, arrhythmias, heart failure 6
• Aggressive management of respiratory conditions, infection prevention

5. Functional Status Optimization:

• Cardiac rehabilitation - improves functional capacity and quality of life 6
• Physical and occupational therapy assessment 6
• Monitor disability progression using Katz index 3

6. Additional Considerations:

• Endocarditis prophylaxis for dental procedures 6
• Optimal dental hygiene 6
• Cardiovascular risk factor modification 6

Prognosis and Counseling

Without Intervention

• Mortality approximately 2% per month once symptomatic 5
• 50% mortality within 2 years of symptom onset 5
• Conservative management in octogenarians shows 6-month survival of only 81.8%, dropping to 57.3% at 24 months 2

With TAVI

• Planned intervention reduces mortality by 32% compared to conservative management (HR 0.68) 2
• 30% mortality at 3 years, with non-cardiac causes predominating after 6 months 6
• Survival strongly influenced by frailty status and comorbidities 3
• Patients with FIMS score ≥1.28 have nearly 3-fold higher 6-year mortality risk 3

Common Pitfalls to Avoid

1. Delaying referral - Every month of delay increases mortality risk by 2% 5
2. Attempting medical optimization instead of intervention - No medical therapy improves outcomes 5
3. Assuming patient is "too old" for intervention - Age alone should not preclude TAVI; functional status and frailty are more important 3, 2
4. Missing concurrent cardiac amyloidosis - Changes management sequence (TAVI first, then reassess for transthyretin stabilizers) 4
5. Inadequate post-procedure coordination - Fragmented care increases readmissions 6